Filing metadata

Accession number
0001209191-23-059432
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Dec 21, 2023
Reporting period
Dec 19, 2023
Description
Insider transaction

Explore SEC Filings Hub